Industry stakeholders to discuss import safety
Executive Summary
An import "safety summit" being convened July 9 will feature a multi-stakeholder medical products panel moderated by FDA Commissioner Andrew von Eschenbach. The Pharmaceutical Research and Manufacturers of America publicized the summit in concert with HHS' July 1 announcement of progress in implementing the "Action Plan for Import Safety," released in November 2007. The summit is intended to facilitate input in designing remedies to import safety problems. Other cosponsors include the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Consumer Healthcare Products Association, the American National Standards Institute, and associations of the food, retail and toy industries. HHS Secretary Michael Leavitt will keynote the event
You may also be interested in...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.